P Bossi
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, Knox S, Strasser F. Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide. Ann Oncol 2018; 29:1718-1726.
Aug 1, 2018Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
Aug 1, 2018Ann Oncol 2018; 29:1718-1726
Scotté F, Bossi P, Carola E, Cudennec T, Dielenseger P, Gomes F, Knox S, Strasser Florian
Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
Siano M, Resteghini c, Licitra L, Bossi P (2015). Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis.
Sep 29, 2015Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
Sep 29, 2015ESMO 2015
Siano Marco, Resteghini c, Licitra L, Bossi P
Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy
Bossi P, Siano M. Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy. JCO Journal of Clinical Oncology 2013; 31
May 25, 2013Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy
May 25, 2013JCO Journal of Clinical Oncology 2013; 31
Bossi P, Siano Marco